Document Detail


Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but subsequent loss of muscle function.
MedLine Citation:
PMID:  7593059     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We studied the effect of flurbiprofen, a non-steroidal anti-inflammatory drug, on muscles that had been subjected to exercise-induced injury. The muscles of the anterior compartment in the limbs of rabbits were cyclically activated as the ankle was simultaneously moved through passive plantar flexion every two seconds for thirty minutes. This treatment imposed acute passive lengthening (eccentric contractions) of the maximally contracted muscles of the anterior compartment. After the eccentric contraction-induced muscle injury, one group of rabbits was treated with oral administration of flurbiprofen, two times a day for six days, while the other group of rabbits served as untreated controls. The contractile, histological, and ultrastructural properties of the muscles were measured before the initial exercise and at three, seven, and twenty-eight days afterward. The group that was treated with flurbiprofen demonstrated a more complete functional recovery than the untreated controls at three and seven days but had a deficit in torque and force generation at twenty-eight days. The administration of flurbiprofen also resulted in a dramatic preservation of the intermediate filament protein desmin. After three days, the proportion of fibers of the extensor digitorum longus that lost desmin-staining was significantly greater in the untreated controls than in the treated animals (34 +/- 4.1 compared with 2.9 +/- 1.7 per cent) (p < 0.001), a finding that supports the concept of a short-term protective effect. However, the muscles in the treated animals still mounted a dramatic regenerative response, as indicated by the expression of embryonic myosin. Early in the recovery period (at three days), significantly fewer fibers of the extensor digitorum longus (2.2 +/- 1.4 per cent) expressed embryonic myosin in the treated animals than in the untreated controls (11.8 +/- 1.9 per cent) (p < 0.001). However, at seven days, the expression of embryonic myosin by the muscles from the treated animals (19.5 +/- 11.9 per cent) actually exceeded that of the muscles from the untreated controls (16.2 +/- 4.1 per cent). This finding suggests either a delayed or an ineffectual regenerative response by the muscles in the treated animals.
Authors:
D K Mishra; J Fridén; M C Schmitz; R L Lieber
Related Documents :
2382729 - Myosin isoforms in neonatal rat extensor digitorum longus, diaphragm, and soleus muscles.
3730499 - "crystalline" myosin cross-bridge array in relaxed bony fish muscle. low-angle x-ray di...
125749 - Comparative studies on 5,5'-dithiobis-(2-nitrobenzioc acid)-treated myosins.
2254439 - Calcium regulated thin filaments from molluscan catch muscles contain a caldesmon-like ...
15504719 - Effect of caldesmon on the position and myosin-induced movement of smooth muscle tropom...
14578909 - Load-dependent kinetics of force production by smooth muscle myosin measured with optic...
6262099 - Analysis of oxime-induced neuromuscular recovery in guinea pig, rat and man following s...
7531309 - Atrial natriuretic peptide in the innervation of the bovine heart conduction system: re...
2450179 - The impact of time after portacaval shunt in the rat on behavior, brain serotonin, and ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of bone and joint surgery. American volume     Volume:  77     ISSN:  0021-9355     ISO Abbreviation:  J Bone Joint Surg Am     Publication Date:  1995 Oct 
Date Detail:
Created Date:  1995-11-27     Completed Date:  1995-11-27     Revised Date:  2010-10-25    
Medline Journal Info:
Nlm Unique ID:  0014030     Medline TA:  J Bone Joint Surg Am     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1510-9     Citation Subset:  AIM; IM; S    
Affiliation:
Department of Orthopaedics, Veterans Administration Medical Center, San Diego, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analgesics / pharmacology,  therapeutic use
Animals
Anti-Inflammatory Agents, Non-Steroidal / pharmacology,  therapeutic use*
Desmin / drug effects,  metabolism
Flurbiprofen / pharmacology,  therapeutic use*
Isometric Contraction
Male
Muscle Contraction
Muscle Fibers, Skeletal / drug effects,  metabolism,  ultrastructure
Muscle, Skeletal / drug effects*,  physiopathology,  ultrastructure
Myofibrils / drug effects,  ultrastructure
Myosins / drug effects,  metabolism
Physical Exertion / physiology*
Rabbits
Regeneration / drug effects
Time Factors
Grant Support
ID/Acronym/Agency:
AR 40050/AR/NIAMS NIH HHS
Chemical
Reg. No./Substance:
0/Analgesics; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/Desmin; 5104-49-4/Flurbiprofen; EC 3.6.4.1/Myosins
Comments/Corrections
Comment In:
J Bone Joint Surg Am. 1997 Aug;79(8):1270-1   [PMID:  9278088 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of an articulated external fixator for fractures of the tibial plafond.
Next Document:  Retrograde intramedullary nailing, without reaming, of fractures of the femoral shaft in multiply in...